Skip to main content
Erschienen in: AIDS and Behavior 8/2011

01.11.2011 | Brief Report

Performances on the CogState and Standard Neuropsychological Batteries Among HIV Patients Without Dementia

Erschienen in: AIDS and Behavior | Ausgabe 8/2011

Einloggen, um Zugang zu erhalten

Abstract

HIV-associated neurocognitive disorders remain prevalent but challenging to diagnose particularly among non-demented individuals. To determine whether a brief computerized battery correlates with formal neurocognitive testing, we identified 46 HIV-infected persons who had undergone both formal neurocognitive testing and a brief computerized battery. Simple detection tests correlated best with formal neuropsychological testing. By multivariable regression model, 53% of the variance in the composite Global Deficit Score was accounted for by elements from the brief computerized tool (P < 0.01). These data confirm previous correlation data with the computerized battery. Using the five significant parameters from the regression model in a Receiver Operating Characteristic curve, 90% of persons were accurately classified as being cognitively impaired or not. The test battery requires additional evaluation, specifically for identifying persons with mild impairment, a state upon which interventions may be effective.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69:1789–99.PubMedCrossRef Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69:1789–99.PubMedCrossRef
2.
Zurück zum Zitat Woods SP, Moran LM, Carey CL, Dawson, Iudicello JE, Gibson S, HIV Neurobehavioral Research Center Group., et al. Prospective memory in HIV infection: is “remembering to remember” a unique predictor of self-reported medication management? Arch Clin Neuropsychol. 2008;23:257–70.PubMedCrossRef Woods SP, Moran LM, Carey CL, Dawson, Iudicello JE, Gibson S, HIV Neurobehavioral Research Center Group., et al. Prospective memory in HIV infection: is “remembering to remember” a unique predictor of self-reported medication management? Arch Clin Neuropsychol. 2008;23:257–70.PubMedCrossRef
3.
Zurück zum Zitat Marcotte TD, Lazzaretto D, Scott JC, Roberts E, Woods SP, Letendre S, et al. Visual attention deficits are associated with driving accidents in cognitively-impaired HIV-infected individuals. J Clin Exp Neuropsychol. 2006;28:13–28.PubMedCrossRef Marcotte TD, Lazzaretto D, Scott JC, Roberts E, Woods SP, Letendre S, et al. Visual attention deficits are associated with driving accidents in cognitively-impaired HIV-infected individuals. J Clin Exp Neuropsychol. 2006;28:13–28.PubMedCrossRef
4.
Zurück zum Zitat Heaton RK, Velin RA, McCutchan JA, Gulevich SJ, Atkinson JH, Wallace MR, et al. Neuropsychological impairment in human immunodeficiency virus-infection: implications for employment. HNRC Group. HIV Neurobehavioral Research Center. Psychosom Med. 1994;56:8–17.PubMed Heaton RK, Velin RA, McCutchan JA, Gulevich SJ, Atkinson JH, Wallace MR, et al. Neuropsychological impairment in human immunodeficiency virus-infection: implications for employment. HNRC Group. HIV Neurobehavioral Research Center. Psychosom Med. 1994;56:8–17.PubMed
5.
Zurück zum Zitat Sevigny JJ, Albert SM, McDermott MP, Schifitto G, McArthur JC, Sacktor N, et al. An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection. Arch Neurol. 2007;64:97–102.PubMedCrossRef Sevigny JJ, Albert SM, McDermott MP, Schifitto G, McArthur JC, Sacktor N, et al. An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection. Arch Neurol. 2007;64:97–102.PubMedCrossRef
6.
Zurück zum Zitat Effros RB, Fletcher CV, Gebo K, Halter JB, Hazzard WR, Horne FM, et al. Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. Clin Infect Dis. 2008;15:542–53.CrossRef Effros RB, Fletcher CV, Gebo K, Halter JB, Hazzard WR, Horne FM, et al. Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. Clin Infect Dis. 2008;15:542–53.CrossRef
7.
Zurück zum Zitat Robertson KR, Smurzynski M, Parsons TD, Wu K, Bosch RJ, Wu J, et al. The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS. 2007;12:1915–21.CrossRef Robertson KR, Smurzynski M, Parsons TD, Wu K, Bosch RJ, Wu J, et al. The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS. 2007;12:1915–21.CrossRef
8.
Zurück zum Zitat Simioni S, Cavassini M, Annoni J, Rimbault Abraham A, Bourquin I, Schiffer V, et al. Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS. 2010;24:1243–50.PubMed Simioni S, Cavassini M, Annoni J, Rimbault Abraham A, Bourquin I, Schiffer V, et al. Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS. 2010;24:1243–50.PubMed
9.
Zurück zum Zitat Sacktor NC, Wong M, Nakasujja N, Skolasky RL, Selnes OA, Musisi S, et al. The international HIV dementia scale: a new rapid screening test for HIV dementia. AIDS. 2005;19:1367–74.PubMed Sacktor NC, Wong M, Nakasujja N, Skolasky RL, Selnes OA, Musisi S, et al. The international HIV dementia scale: a new rapid screening test for HIV dementia. AIDS. 2005;19:1367–74.PubMed
10.
Zurück zum Zitat Bottiggi KA, Chang JJ, Schmitt FA, Avison MJ, Mootoor Y, Nath A, et al. The HIV dementia scale: predictive power in mild dementia and HAART. J Neurol Sci. 2007;260:11–5.PubMedCrossRef Bottiggi KA, Chang JJ, Schmitt FA, Avison MJ, Mootoor Y, Nath A, et al. The HIV dementia scale: predictive power in mild dementia and HAART. J Neurol Sci. 2007;260:11–5.PubMedCrossRef
11.
Zurück zum Zitat Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.PubMedCrossRef Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.PubMedCrossRef
13.
Zurück zum Zitat Cysique LA, Maruff P, Darby D, Brew BJ. The assessment of cognitive function in advanced HIV-1 infection and AIDS dementia complex using a new computerised cognitive test battery. Arch Clin Neuropsychol. 2006;21:85–94.CrossRef Cysique LA, Maruff P, Darby D, Brew BJ. The assessment of cognitive function in advanced HIV-1 infection and AIDS dementia complex using a new computerised cognitive test battery. Arch Clin Neuropsychol. 2006;21:85–94.CrossRef
14.
Zurück zum Zitat Winston A, Garvey L, Scotney E, Yerrakalva D, Allsop JM, Thomson EC, et al. Does acute hepatitis C infection affect the central nervous system in HIV-1 infected individuals? J Viral Hepat. 2010;17:419–26.PubMedCrossRef Winston A, Garvey L, Scotney E, Yerrakalva D, Allsop JM, Thomson EC, et al. Does acute hepatitis C infection affect the central nervous system in HIV-1 infected individuals? J Viral Hepat. 2010;17:419–26.PubMedCrossRef
15.
Zurück zum Zitat Vellozzi C, Brooks JT, Bush TJ, Conley LJ, Henry K, Carpenter CC, et al. The study to understand the natural history of HIV and AIDS in the era of effective therapy (SUN Study). Am J Epidemiol. 2009;169:642–52.PubMedCrossRef Vellozzi C, Brooks JT, Bush TJ, Conley LJ, Henry K, Carpenter CC, et al. The study to understand the natural history of HIV and AIDS in the era of effective therapy (SUN Study). Am J Epidemiol. 2009;169:642–52.PubMedCrossRef
16.
Zurück zum Zitat Heaton RK, Clifford DB, Franklin DR, Woods SP, Ake C, Vaida F, et al. HIV-associated neurocogntive disorders persisint in the era od poetent antiretroviral therapy. Neurology. 2010;75:2087–96.PubMedCrossRef Heaton RK, Clifford DB, Franklin DR, Woods SP, Ake C, Vaida F, et al. HIV-associated neurocogntive disorders persisint in the era od poetent antiretroviral therapy. Neurology. 2010;75:2087–96.PubMedCrossRef
17.
Zurück zum Zitat Letendre SL, Marquie-Beck J, Ellis RJ, Woods SP, Best B, Clifford DB, et al. The role of cohort studies in drug development: clinical evidence of antiviral activity of serotonin reuptake inhibitors and HMG-CoA reductase inhibitors in the central nervous system. J Neuroimmune Pharmacol. 2007;2:120–7.PubMedCrossRef Letendre SL, Marquie-Beck J, Ellis RJ, Woods SP, Best B, Clifford DB, et al. The role of cohort studies in drug development: clinical evidence of antiviral activity of serotonin reuptake inhibitors and HMG-CoA reductase inhibitors in the central nervous system. J Neuroimmune Pharmacol. 2007;2:120–7.PubMedCrossRef
18.
Zurück zum Zitat Army Individual Test Battery. Manual of directions and scoring. Washington: War Department, Adjutant General’s Office; 1994. Army Individual Test Battery. Manual of directions and scoring. Washington: War Department, Adjutant General’s Office; 1994.
19.
Zurück zum Zitat Gladsjo JA, Schuman CC, Evans JD, Peavy GM, Miller SW, Heaton RK. Norms for letter and category fluency: demographic corrections for age, education, and ethnicity. Assessment. 1999;6:147–78.PubMedCrossRef Gladsjo JA, Schuman CC, Evans JD, Peavy GM, Miller SW, Heaton RK. Norms for letter and category fluency: demographic corrections for age, education, and ethnicity. Assessment. 1999;6:147–78.PubMedCrossRef
20.
Zurück zum Zitat Heaton RK, Grant I, Matthews CG. Comprehensive norms for an expanded Halstead-Reitan battery: demographic corrections, research findings, and clinical applications. Odessa: Psychological Assessment Resources, Inc; 1991. Heaton RK, Grant I, Matthews CG. Comprehensive norms for an expanded Halstead-Reitan battery: demographic corrections, research findings, and clinical applications. Odessa: Psychological Assessment Resources, Inc; 1991.
21.
Zurück zum Zitat Heaton RK, Taylor MJ, Manly JJ. Demographic effects and use of demographically corrected norms with theWAIS-III and WMS-III. In: Tulsky DS, Heaton RK, Chelune G, Ivnik R, Bornstein RA, Prifitera A, Ledbetter M, editors. Clinical interpretation of the WAIS-III and WMSIII. San Diego: Academic Press; 2002. Heaton RK, Taylor MJ, Manly JJ. Demographic effects and use of demographically corrected norms with theWAIS-III and WMS-III. In: Tulsky DS, Heaton RK, Chelune G, Ivnik R, Bornstein RA, Prifitera A, Ledbetter M, editors. Clinical interpretation of the WAIS-III and WMSIII. San Diego: Academic Press; 2002.
22.
Zurück zum Zitat Wechsler D. The Psychological Corporation. (1997). Wechsler adult intelligence scale. 3rd edn. (WAIS-III). San Antonio. Wechsler D. The Psychological Corporation. (1997). Wechsler adult intelligence scale. 3rd edn. (WAIS-III). San Antonio.
23.
Zurück zum Zitat Diehr MC, Heaton RK, Miller W, Grant I. The paced auditory serial addition task (PASAT): norms for age, education, and ethnicity. Assessment. 1998;5:375–87.PubMedCrossRef Diehr MC, Heaton RK, Miller W, Grant I. The paced auditory serial addition task (PASAT): norms for age, education, and ethnicity. Assessment. 1998;5:375–87.PubMedCrossRef
24.
Zurück zum Zitat Gronwall DM. Paced auditory serial-addition task: a measure of recovery from concussion. Percept Mot Skills. 1977;44:367–73.PubMedCrossRef Gronwall DM. Paced auditory serial-addition task: a measure of recovery from concussion. Percept Mot Skills. 1977;44:367–73.PubMedCrossRef
25.
Zurück zum Zitat Kløve H. Clinical neuropsychology. In: Forster FM, editor. The medical clinics of north America. New York: Saunders; 1963. Kløve H. Clinical neuropsychology. In: Forster FM, editor. The medical clinics of north America. New York: Saunders; 1963.
26.
Zurück zum Zitat Benedict RH. Brief visuospatial memory test—revised. Odessa: Psychological Assessment Resources, Inc; 1997. Benedict RH. Brief visuospatial memory test—revised. Odessa: Psychological Assessment Resources, Inc; 1997.
27.
Zurück zum Zitat Benedict RHB, Schretlen D, Groninger L, Brandt J. Hopkins verbal learning test–revised: normative data and analysis of inter-formand test-retest reliability. Clin Neuropsychol. 1998;12:43–55. Benedict RHB, Schretlen D, Groninger L, Brandt J. Hopkins verbal learning test–revised: normative data and analysis of inter-formand test-retest reliability. Clin Neuropsychol. 1998;12:43–55.
28.
Zurück zum Zitat Kongs SK, Thompson LL, Iverson GL, Heaton RK. Wisconsin card sorting test—64 card computerized version. Odessa: Psychological Assessment Resources; 2000. Kongs SK, Thompson LL, Iverson GL, Heaton RK. Wisconsin card sorting test—64 card computerized version. Odessa: Psychological Assessment Resources; 2000.
29.
Zurück zum Zitat Benton AL, Hamsher K, Sivan AB. Multilingual aphasia examination. Iowa City: AJA Associates; 1994. Benton AL, Hamsher K, Sivan AB. Multilingual aphasia examination. Iowa City: AJA Associates; 1994.
30.
Zurück zum Zitat Reitan RM, Wolfson D. The Halstead-Reitan neuropsychological test battery: theory and clinical interpretation. Tucson: Neuropsychology Press; 1993. Reitan RM, Wolfson D. The Halstead-Reitan neuropsychological test battery: theory and clinical interpretation. Tucson: Neuropsychology Press; 1993.
31.
Zurück zum Zitat Howell DC. Statistical methods for psychology. 5th edn. Pacific Grove: Duxbury Thomas Learning; 2002. Howell DC. Statistical methods for psychology. 5th edn. Pacific Grove: Duxbury Thomas Learning; 2002.
32.
Zurück zum Zitat Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte TD, Grant I, Group HNRC. Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol. 2004;26:307–19.PubMedCrossRef Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte TD, Grant I, Group HNRC. Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol. 2004;26:307–19.PubMedCrossRef
33.
Zurück zum Zitat Kortte KB, Horner MD, Windham WK. The trail making test, part B: cognitive flexibility or ability to maintain set? Appl Neuropsychol. 2002;9:106–9.PubMedCrossRef Kortte KB, Horner MD, Windham WK. The trail making test, part B: cognitive flexibility or ability to maintain set? Appl Neuropsychol. 2002;9:106–9.PubMedCrossRef
34.
Zurück zum Zitat Hardy DJ, Hinkin CH. Reaction time performance in adults with HIV/AIDS. J Clin Exp Neuropsychol. 2002;24:912–29.PubMedCrossRef Hardy DJ, Hinkin CH. Reaction time performance in adults with HIV/AIDS. J Clin Exp Neuropsychol. 2002;24:912–29.PubMedCrossRef
Metadaten
Titel
Performances on the CogState and Standard Neuropsychological Batteries Among HIV Patients Without Dementia
Publikationsdatum
01.11.2011
Erschienen in
AIDS and Behavior / Ausgabe 8/2011
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-011-0033-9

Weitere Artikel der Ausgabe 8/2011

AIDS and Behavior 8/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Chronisches Koronarsyndrom: Gefahr von Hospitalisierung wegen Herzinsuffizienz

06.05.2024 Herzinsuffizienz Nachrichten

Obwohl ein rezidivierender Herzinfarkt bei chronischem Koronarsyndrom wahrscheinlich die Hauptsorge sowohl der Patienten als auch der Ärzte ist, sind andere Ereignisse womöglich gefährlicher. Laut einer französischen Studie stellt eine Hospitalisation wegen Herzinsuffizienz eine größere Gefahr dar.

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

„Restriktion auf vier Wochen Therapie bei Schlaflosigkeit ist absurd!“

06.05.2024 Insomnie Nachrichten

Chronische Insomnie als eigenständiges Krankheitsbild ernst nehmen und adäquat nach dem aktuellen Forschungsstand behandeln: Das forderte der Schlafmediziner Dr. Dieter Kunz von der Berliner Charité beim Praxis Update.

GLP-1-Rezeptoragonisten und SGLT-2-Hemmer: zusammen besser

06.05.2024 Typ-2-Diabetes Nachrichten

Immer häufiger wird ein Typ-2-Diabetes sowohl mit einem GLP-1-Rezeptor-Agonisten als auch mit einem SGLT-2-Inhibitor behandelt. Wie sich das verglichen mit den Einzeltherapien auf kardiovaskuläre und renale Komplikationen auswirkt, wurde anhand von Praxisdaten aus Großbritannien untersucht.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.